These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11318969)

  • 1. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.
    Handelman GJ; Walter MF; Adhikarla R; Gross J; Dallal GE; Levin NW; Blumberg JB
    Kidney Int; 2001 May; 59(5):1960-6. PubMed ID: 11318969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients.
    Ferraro B; Galli F; Frei B; Kingdon E; Canestrari F; Rice-Evans C; Buoncristiani U; Davenport A; Moore KP
    Kidney Int; 2003 Jun; 63(6):2207-13. PubMed ID: 12753309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
    Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients.
    Lim PS; Chang YM; Thien LM; Wang NP; Yang CC; Chen TT; Hsu WM
    Blood Purif; 2002; 20(6):537-42. PubMed ID: 12566669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.
    Rivara MB; Ikizler TA; Ellis CD; Mehrotra R; Himmelfarb J
    BMC Nephrol; 2015 Jun; 16():79. PubMed ID: 26045064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis.
    Salahudeen AK; Oliver B; Bower JD; Roberts LJ
    Kidney Int; 2001 Oct; 60(4):1525-31. PubMed ID: 11576368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure.
    Wiswedel I; Hirsch D; Carluccio F; Hampl H; Siems W
    Biofactors; 2005; 24(1-4):201-8. PubMed ID: 16403981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and inflammation in hemodialysis patients.
    Spittle MA; Hoenich NA; Handelman GJ; Adhikarla R; Homel P; Levin NW
    Am J Kidney Dis; 2001 Dec; 38(6):1408-13. PubMed ID: 11728983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
    Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
    J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
    Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
    Boaz M; Iuliano L; Himmelfarb J; Matas Z; Micheletta F; McMonagle E; Friedman V; Natoli S; Gvirtz G; Biro A; Smetana S; Sabo G; Gafter U; Weinstein T
    Nephron Clin Pract; 2005; 100(4):c111-9. PubMed ID: 15849477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
    Ikizler TA; Morrow JD; Roberts LJ; Evanson JA; Becker B; Hakim RM; Shyr Y; Himmelfarb J
    Clin Nephrol; 2002 Sep; 58(3):190-7. PubMed ID: 12356187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy.
    Walter MF; Blumberg JB; Dolnikowski GG; Handelman GJ
    Anal Biochem; 2000 Apr; 280(1):73-9. PubMed ID: 10805523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia.
    Wiswedel I; Peter D; Gardemann A; Carluccio F; Hampl H; Siems W
    Biomark Insights; 2008 May; 3():419-428. PubMed ID: 19578522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.
    Morrow JD; Frei B; Longmire AW; Gaziano JM; Lynch SM; Shyr Y; Strauss WE; Oates JA; Roberts LJ
    N Engl J Med; 1995 May; 332(18):1198-203. PubMed ID: 7700313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
    Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
    Montazerifar F; Hashemi M; Karajibani M; Dikshit M
    J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.